Inorganic element determinations: Arguments for their reimbursement by French National system of health insurance

被引：0

作者：

Arnaud, Josiane ^{[1
]}

Beauval, Nicolas ^{[2
]}

Bost, Muriel ^{[3
,4
]}

Fofou-Caillierez, Ma'atem Beatrice ^{[5
]}

El Balkhi, Souleiman ^{[6
]}

Garnier, Robert ^{[7
]}

Lelievre, Benedicte ^{[8
]}

Romain, Sarah ^{[9
]}

Bouchet, Martine Ropert ^{[10
]}

Sadeg, Nouredine ^{[11
]}

Goulle, Jean Pierre ^{[12
]}

机构：

[1] CHU Grenoble Alpes, Unite Biochim Hormonale & Nutr, Grenoble, France

[2] CHU Lille, Unite Fonct Toxicol, Lille, France

[3] Hosp Civils Lyon, Ctr Reference Natl Malad Wilson, Bron, France

[4] Hosp Civils Lyon, Ctr Biol & Anatomopathol Sud, Lab Anal Trace Biochim & Biol Mol, Pierre Benite, France

[5] CHRU Nancy, Lab Biochim Biol Mol Nutr, Vandoeuvre Les Nancy, France

[6] CHU Limoges, Serv Pharmacol Toxicol & Pharmacovigilance, Toxicol Analyt Environnem & Sante Travail, Limoges, France

[7] Hop Fernand Widal, Ctr Antipoison Paris, Paris, France

[8] CHU Angers, Lab Pharmacol Toxicol, Angers, France

[9] CHRU Strasbourg, Lab Biochim & Biol Mol, Strasbourg, France

[10] CHU Rennes, Lab Biochim Toxicol, Rennes, France

[11] Int Med Inst Toxicol & Pharmacol IMITOX, Chambly, France

[12] Univ Rouen, Dept Pharm, Aliments Bioproc, Toxicol,Environm, Rouen, France

来源：

ANNALES DE BIOLOGIE CLINIQUE | 2021年 / 79卷 / 04期

关键词：

D O I：

10.1684/abc.2021.1654

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：383 / 385

页数：3

共 50 条

[1] Inorganic element determinations: Arguments for their reimbursement by French national system of health insurance
Arnaud, Josiane
Beauval, Nicolas
Bost, Muriel
Fofou-Callierez, Ma'atem Beatrice
El Balkhi, Souleiman
Garnier, Robert
Lelievre, Benedicte
Romain, Sarah
Bouchet, Martine Ropert
Sadeg, Nouredine
Goulle, Jean Pierre
[J]. TOXICOLOGIE ANALYTIQUE ET CLINIQUE, 2020, 32 (01) : 33 - 61
[2] HOSPITAL REIMBURSEMENT UNDER NATIONAL-HEALTH INSURANCE
LAVE, JR
LAVE, LB
[J]. HEALTH COMMUNICATIONS AND INFORMATICS, 1979, 5 (5-6) : 304 - 318
[3] Prescribing outside the limits of marketing authorizations and reimbursement by the French universal health insurance system
Avouac, B
[J]. JOINT BONE SPINE, 2002, 69 (06) : 534 - 537
[4] Physicians' perception of the reform of the review and assessment system of national health insurance reimbursement claims
Lee, Jung Chan
Kim, Kye Hyun
[J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (12): : 841 - 849
[5] THE FINANCIAL IMPACT OF FEBUXOSTAT REIMBURSEMENT TO THE TAIWAN NATIONAL HEALTH INSURANCE
Liu, P. J.
Lu, Z. F.
Hsu, C. N.
Chan, Y. Y.
[J]. VALUE IN HEALTH, 2019, 22 : S594 - S594
[6] CLAIMS REIMBURSEMENT ANALYSIS OF THE NATIONAL HEALTH INSURANCE SCHEME IN GHANA
Nsiah-Boateng, E.
[J]. VALUE IN HEALTH, 2014, 17 (07) : A432 - A432
[7] Evolution of Opioids Reimbursement since 2004 from the National Database of the General Health Insurance System
Pauly, Vanessa
Pradel, Vincent
Frauger, Elisabeth
Micallef, Joelle
Thirion, Xavier
[J]. THERAPIE, 2011, 66 (04): : 369 - 372
[8] REIMBURSEMENT LAG OF INNOVATIVE NEW DRUGS UNDER TAIWAN'S NATIONAL HEALTH INSURANCE SYSTEM
Shih, Y.
Wang, C.
Wen, Y.
Chen, Y.
Lin, F.
Hsiao, F.
[J]. VALUE IN HEALTH, 2017, 20 (05) : A43 - A43
[9] French national health insurance information system and the permanent beneficiaries sample
Tuppin, P.
de Roquefeuil, L.
Weill, A.
Ricordeau, P.
Merliere, Y.
[J]. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2010, 58 (04): : 286 - 290
[10] French Health big data experience: The evolution of the national health insurance information system
Le Meur, N.
Gao, F.
[J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2020, 30

← 1 2 3 4 5 →